To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. 

Please contact us at: 416-441-0788, toll-free: 1-877-341-0788 or mail@opatoday.com.

Publications

  • New Drugs/Drug News 2011, Volume 29, No. 1

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Update on Sulfonamide Allergy and Cross-Reactivity

  • Full Financial Statements 2011

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Full audited financial statements for the year ending December 31, 2011.

  • New Drugs/Drug News 2010, Volume 28, No. 5

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Update on ASA/NSAID Sensitivity Reactions

  • Annual Report 2009-10

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    A look at the activities of the Ontario Pharmacists Association over the past Board year (June 2009 – June 2010).

  • New Drugs/Drug News 2010, Volume 28, No. 4

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    First-in-Class Drug Approval: Liraglutide (Victoza – Novo Nordisk Canada Inc.) for Type 2 Diabetes

  • New Drugs/Drug News 2010, Volume 28, No. 3

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    New Antiplatelet Agent: Prasugrel (Effient – Eli Lilly Canada Inc.)

  • New Drugs/Drug News 2010, Volume 28, No. 2

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    New Antibiotic for Complicated Skin and Skin Structure Infections: Telavancin (Vibativ – Astellas Pharma Canada, Inc.)

  • DIRC Bulletin – Volume 11, Number 1

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

  • New Drugs/Drug News 2010, Volume 28, No. 1

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Clinical Update: Dyslipidemia And Prevention of Cardiovascular Disease

  • New Drugs/Drug News 2009, Volume 27, No. 6

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Pandemic H1N1 Vaccine: Frequently Asked Questions

Back to top